Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Outcome of the first 200 patients with prostate cancer treated with MRI-Linac at Assuta MC.

Autor: Gelbart Pridan O; The Adelson School of Medicine, Ariel University, Ariel, Israel., Ben David MA; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Zalmanov S; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Lipski Y; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Grinberg V; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Levin D; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Apter S; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Guindi M; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.; Innovation Division, Assuta Medical Center, Tel Aviv, Israel., Epstein D; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Radus R; Radiation Oncology Department, Rabin Medical Center, Petah-Tikva, Israel., Arsenault O; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Hod K; Department of Academy and Research, Assuta Medical Center, Tel Aviv, Israel., Tamami Q; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel., Pfeffer R; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Mar 23; Vol. 13, pp. 1151256. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).